Search

everythinglearnresearchcommunity

for

Search:↓

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Low-dose spironolactone is safe and effective for treating hirsutism.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Gut microbes significantly affect brain steroid levels.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

Testosterone levels aren't important for depression in men, but some other hormones might affect certain symptoms.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Low estrogen compared to androgen may cause female hair loss.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.